Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice

npj Biofilms and Microbiomes

Volumn 2, Issue , 2016, Pages

  Udayappan, Shanthadevi ^a   Manneras Holm, Louise ^b   Chaplin Scott, Alice ^a   Belzer, Clara ^c   Herrema, Hilde ^a   Dallinga Thie, Geesje M ^a   Duncan, Silvia H ^d   Stroes, Erik S G ^a   Groen, Albert K ^e   Flint, Harry J ^d   Backhed, Fredrik ^b,f   De Vos, Willem M ^c,g   Nieuwdorp, Max ^a,b,h,i  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d ROWETT RESEARCH INSTITUTE   (United Kingdom)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f Capital Region   (Denmark)

^g UNIVERSITY OF HELSINKI   (Finland)

^h Diabetes Center   (Netherlands)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85029701997     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/npjbiofilms.2016.9     Document Type: Article

References (33)

1. Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E. & Williamson, D. F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 8, 29 (2010).
2. Khan, M. T., Nieuwdorp, M. & Backhed, F. Microbial modulation of insulin sensitivity. Cell Metab. 20, 753-760 (2014).
3. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
4. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
5. Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517 (2009).
6. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
7. Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916 917 (2012).
8. Louis, P., Young, P., Holtrop, G. & Flint, H. J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-Transferase gene. Environ. Microbiol. 12, 304-314 (2010).
9. Duncan, S. H., Louis, P. & Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microb. 70, 5810-5817 (2004).
10. Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl Acad. Sci. USA 108, 4523-4530 (2011).
11. Hylemon, P. B. et al. Bile acids as regulatory molecules. J. Lipid Res. 50, 1509-1520 (2009).
12. Sinal, C. J. et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744 (2000).
13. Beuling, E. et al. Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine. Gut 59, 888-895 (2010).
14. Whorwell, P. J. et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol. 101, 1581-1590 (2006).
15. Everard, A. et al. Cross-Talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066-9071 (2013).
16. De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96 (2014).
17. Dawson, P. A., Lan, T. & Rao, A. Bile acid transporters. J. Lipid Res. 50, 2340-2357 (2009).
18. Chiang, J. Y. L. Bile acids: Regulation of synthesis. J. Lipid Res. 50, 1955-1966 (2009).
19. Begley, M., Hill, C. & Gahan, C. G. M. Bile salt hydrolase activity in probiotics. Appl. Environ. Microb. 72, 1729-1738 (2006).
20. Joyce, S. A. et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc. Natl Acad. Sci. USA 111, 7421-7426 (2014).
21. Out, C. et al. Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport. J. Hepatol. 61, 351-357 (2014).
22. Miyata, M., Takamatsu, Y., Kuribayashi, H. & Yamazoe, Y. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J. Pharmacol. Exp. Ther. 331, 1079-1085 (2009).
23. Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4: 2384. (2013).
24. Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S. & Moschetta, A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 7, 12-18 (2014).
25. Fang, S. et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21, 159-165 (2015).
26. Kir, S. et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331, 1621-1624 (2011).
27. de Vos, W. M. & Nieuwdorp, M. GENOMICS: A gut prediction. Nature 498, 48-49 (2013).
28. Cansby, E. et al. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet. FASEB J. 27, 3660-3671 (2013).
29. Ramirez-Farias, C. et al. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 101, 541-550 (2009).
30. Rajilic-Stojanovic, M. et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: Analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 11, 1736-1751 (2009).
31. Lahti, L., Elo, L. L., Aittokallio, T. & Kaski, S. Probabilistic analysis of probe reliability in differential gene expression studies with short oligonucleotide arrays. IEEE/ACM Trans. Comput. Biol. 8, 217-225 (2011).
32. Braak, C. J. F., Ter Smilauer, P. Canoco reference manual and user's guide: software for ordination, version 5.0. m. Microcomputer Power - p496. Ithaca, USA (2012).
33. Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225-235 (2013).